AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Takahashi, N.
Right arrow Articles by Chari, S. T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, N.
Right arrow Articles by Chari, S. T.
DOI:10.2214/AJR.07.2309
AJR 2008; 190:280-286
© American Roentgen Ray Society

Original Research

Dual-Phase CT of Autoimmune Pancreatitis: A Multireader Study

Naoki Takahashi1, Joel G. Fletcher1, Jeff L. Fidler1, David M. Hough1, Akira Kawashima1 and Suresh T. Chari2

1 Department of Radiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905.
2 Department of Internal Medicine, Mayo Clinic, Rochester, MN.

OBJECTIVE. The purpose of this study was to identify findings that aid in differentiating autoimmune pancreatitis from pancreatic carcinoma using dual-phase CT.

MATERIALS AND METHODS. Dual-phase CT scans of 74 patients (25 with autoimmune pancreatitis, 33 with pancreatic carcinoma, and 16 with a normal pancreas) were independently evaluated by three radiologists for enhancement of the pancreas; the presence of a capsule-like rim, peripancreatic strands, and pancreatic calcifications; pancreatic duct or bile duct changes; and renal involvement. The frequency of CT characteristics was compared between autoimmune pancreatitis and carcinoma. Interobserver agreement for the three reviewers for the assessment of CT characteristics was evaluated using kappa statistics.

RESULTS. Diffusely decreased enhancement of the pancreas (autoimmune pancreatitis vs carcinoma: 28% vs 3%; p = 0.02, {kappa} = 0.33–0.75), capsule–like rim (40% vs 9%; p = 0.009, {kappa} = 0.42–0.66), peripancreatic strands (60% vs 27%; p = 0.02, {kappa} = 0.45–0.54), pancreatic calcifications (32% vs 9%; p = 0.04, {kappa} = 0.14–0.47), bile duct wall enhancement (52% vs 6%; p = 0.0001, {kappa} = 0.28–0.47), and renal involvement (28% vs 0%; p = 0.002, {kappa} = 0.32–0.74) were more frequent in patients with autoimmune pancreatitis. Pancreatic duct dilation (24% vs 67%; p = 0.001, {kappa} = 0.65–0.73) and abrupt cutoff (16% vs 55%; p = 0.003, {kappa} = 0.60–0.65) were more frequent in patients with carcinoma.

CONCLUSION. Diffusely decreased enhancement of the pancreas, a capsule-like rim, bile duct enhancement, and renal involvement are useful signs of autoimmune pancreatitis.

Keywords: autoimmune pancreatitis • CT • gastrointestinal tract • pancreas • pancreatic carcinoma






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.